Annual SGA
$185.15 M
+$63.02 M+51.60%
December 31, 2023
Summary
- As of February 8, 2025, ARQT annual SGA is $185.15 million, with the most recent change of +$63.02 million (+51.60%) on December 31, 2023.
- During the last 3 years, ARQT annual SGA has risen by +$163.81 million (+767.72%).
- ARQT annual SGA is now at all-time high.
Performance
ARQT SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$58.82 M
+$644.00 K+1.11%
September 30, 2024
Summary
- As of February 8, 2025, ARQT quarterly SGA is $58.82 million, with the most recent change of +$644.00 thousand (+1.11%) on September 30, 2024.
- Over the past year, ARQT quarterly SGA has increased by +$11.22 million (+23.58%).
- ARQT quarterly SGA is now at all-time high.
Performance
ARQT Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$4.18 B
-$195.53 M-4.91%
September 30, 2024
Summary
- As of February 8, 2025, ARQT TTM SGA is -$4.18 billion, with the most recent change of -$195.53 million (-4.91%) on September 30, 2024.
- Over the past year, ARQT TTM SGA has dropped by -$4.35 billion (-2509.28%).
- ARQT TTM SGA is now -17118.50% below its all-time high of -$24.28 million.
Performance
ARQT TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
ARQT Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +51.6% | +23.6% | -2509.3% |
| 3 y3 years | +767.7% | +23.6% | -2509.3% |
| 5 y5 years | +10000.0% | +23.6% | -2509.3% |
ARQT Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +203.7% | at high | +214.1% | -230.9% | at low |
| 5 y | 5-year | at high | +2701.0% | at high | +2529.3% | -3384.0% | at low |
| alltime | all time | at high | >+9999.0% | at high | +9605.8% | <-9999.0% | at low |
Arcutis Biotherapeutics Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $58.82 M(+1.1%) | $220.46 M(+5.4%) |
| Jun 2024 | - | $58.17 M(+6.2%) | $209.24 M(+6.2%) |
| Mar 2024 | - | $54.79 M(+12.6%) | $197.02 M(+6.4%) |
| Dec 2023 | $185.15 M(+51.6%) | $48.67 M(+2.3%) | $185.15 M(+6.7%) |
| Sep 2023 | - | $47.59 M(+3.6%) | $173.49 M(+7.5%) |
| Jun 2023 | - | $45.96 M(+7.1%) | $161.37 M(+12.8%) |
| Mar 2023 | - | $42.92 M(+15.9%) | $143.04 M(+17.1%) |
| Dec 2022 | $122.12 M(+100.3%) | $37.02 M(+4.4%) | $122.12 M(+17.6%) |
| Sep 2022 | - | $35.47 M(+28.4%) | $103.83 M(+22.4%) |
| Jun 2022 | - | $27.62 M(+25.5%) | $84.83 M(+23.8%) |
| Mar 2022 | - | $22.01 M(+17.5%) | $68.52 M(+12.4%) |
| Dec 2021 | $60.97 M | $18.73 M(+13.7%) | $60.97 M(+24.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | $16.47 M(+45.6%) | $48.93 M(+28.7%) |
| Jun 2021 | - | $11.31 M(-21.7%) | $38.02 M(+17.6%) |
| Mar 2021 | - | $14.45 M(+116.1%) | $32.32 M(+51.5%) |
| Dec 2020 | $21.34 M(+222.8%) | $6.69 M(+20.3%) | $21.34 M(+26.4%) |
| Sep 2020 | - | $5.56 M(-1.0%) | $16.88 M(+23.9%) |
| Jun 2020 | - | $5.62 M(+61.9%) | $13.62 M(+46.0%) |
| Mar 2020 | - | $3.47 M(+55.1%) | $9.33 M(+41.1%) |
| Dec 2019 | $6.61 M(+268.2%) | $2.24 M(-2.7%) | $6.61 M(+32.8%) |
| Sep 2019 | - | $2.30 M(+73.7%) | $4.98 M(+85.9%) |
| Jun 2019 | - | $1.32 M(+76.8%) | $2.68 M(+97.7%) |
| Mar 2019 | - | $749.00 K(+23.6%) | $1.35 M(+123.6%) |
| Dec 2018 | $1.79 M(+158.3%) | $606.00 K | $606.00 K |
| Dec 2017 | $695.00 K | - | - |
FAQ
- What is Arcutis Biotherapeutics annual SGA?
- What is the all time high annual SGA for Arcutis Biotherapeutics?
- What is Arcutis Biotherapeutics annual SGA year-on-year change?
- What is Arcutis Biotherapeutics quarterly SGA?
- What is the all time high quarterly SGA for Arcutis Biotherapeutics?
- What is Arcutis Biotherapeutics quarterly SGA year-on-year change?
- What is Arcutis Biotherapeutics TTM SGA?
- What is the all time high TTM SGA for Arcutis Biotherapeutics?
- What is Arcutis Biotherapeutics TTM SGA year-on-year change?
What is Arcutis Biotherapeutics annual SGA?
The current annual SGA of ARQT is $185.15 M
What is the all time high annual SGA for Arcutis Biotherapeutics?
Arcutis Biotherapeutics all-time high annual SGA is $185.15 M
What is Arcutis Biotherapeutics annual SGA year-on-year change?
Over the past year, ARQT annual SGA has changed by +$63.02 M (+51.60%)
What is Arcutis Biotherapeutics quarterly SGA?
The current quarterly SGA of ARQT is $58.82 M
What is the all time high quarterly SGA for Arcutis Biotherapeutics?
Arcutis Biotherapeutics all-time high quarterly SGA is $58.82 M
What is Arcutis Biotherapeutics quarterly SGA year-on-year change?
Over the past year, ARQT quarterly SGA has changed by +$11.22 M (+23.58%)
What is Arcutis Biotherapeutics TTM SGA?
The current TTM SGA of ARQT is -$4.18 B
What is the all time high TTM SGA for Arcutis Biotherapeutics?
Arcutis Biotherapeutics all-time high TTM SGA is -$24.28 M
What is Arcutis Biotherapeutics TTM SGA year-on-year change?
Over the past year, ARQT TTM SGA has changed by -$4.35 B (-2509.28%)